Entera Bio (ENTX)
(Delayed Data from NSDQ)
$0.71 USD
+0.01 (0.74%)
Updated Sep 22, 2023 03:38 PM ET
4-Sell of 5 4
F Value B Growth F Momentum D VGM
Price, Consensus and EPS Surprise
ENTX 0.71 +0.01(0.74%)
Will ENTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ENTX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ENTX
OPKO Health (OPK) Ties Up for Oral Peptide Tablet Formulations
Entera Bio Ltd. (ENTX) Reports Q1 Loss, Misses Revenue Estimates
ENTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Will Entera Bio Ltd. (ENTX) Report Negative Q1 Earnings? What You Should Know
Entera Bio Ltd. (ENTX) Reports Q4 Loss, Lags Revenue Estimates
Entera Bio (ENTX) to Report Q4 Earnings: What's in the Cards?
Other News for ENTX
Entera Bio Announces Collaboration with OPKO Biologics to Develop Oral Peptide Tablet Formulations for Obesity and Intestinal Malabsorption Syndromes
Entera Bio announces collaboration with OPKO Biologics
Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Entera Bio (ENTX)
Entera Bio to Participate in Upcoming Investor Conferences
Bioventus And 3 Other Stocks Under $5 Insiders Are Buying